QA: Molecular Templates Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001183765_2024_Molecular_Templates_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001183765, Molecular Templates Inc

  xvar xval
0 AssetsCurrent 16,772,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,393,000
3 remainder_Assets 11,218,000
4 LiabilitiesCurrent 17,321,000
5 LiabilitiesNoncurrent 11,148,000
6 remainder_Liabilities 2,702,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,354,817
9 ResearchAndDevelopmentExpense 60,163,776
10 remainder_Expenses 2,199,625
11 remainder_Revenues 1,059,316
12 remainder_NetIncome 46,664,372
13 remainder_ComprehensiveNetIncome 49,602
  yvar yval
0 Assets 35,383,000
1 Liabilities 31,171,000
2 Expenses 83,718,218
3 Revenues 1,059,316
4 StockholdersEquity 4,212,000
5 NetIncome -35,994,530
6 ComprehensiveNetIncome -35,969,729
7 BaseVar 99,022,754
8 EconomicCapitalRatiobeforeLimitedLiability -0.805
9 EconomicCapitalRatio 1.34

Edgar->Model Mapping

Feature Distribution

Change over Time